Use a separate sterile needle and syringe for each injection. Using a sterile needle and syringe and aseptic technique, withdraw and administer a single 0.5 mL dose of Diphtheria and Tetanus Toxoids Adsorbed intramuscularly. Just before use, shake the vial well until a uniform, white, cloudy suspension results. Do not remove either the rubber stopper or the metal seal holding it in place. If these conditions exist, the product should not be administered.Īfter removing the "flip-off" cap, cleanse the vaccine vial stopper with a suitable germicide. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. The first dose of Diphtheria and Tetanus Toxoids Adsorbed may be administered as early as 6 weeks of age. Dosage and Scheduleĭiphtheria and Tetanus Toxoids Adsorbed is approved for administration as a 5 dose series at 2, 4, 6, 15-18 months, and 4-6 years. Tetanus and Diphtheria Vaccine Dosage and Administrationįor intramuscular use only. Diphtheria and Tetanus Toxoids Adsorbed should be used in instances where the pertussis vaccine component is contraindicated.ĭiphtheria and Tetanus Toxoids Adsorbed is not to be used for treatment of diphtheria or tetanus infection. Diphtheria and Tetanus Toxoids Adsorbed is approved for use in children from 6 weeks through 6 years of age (prior to 7 th birthday).ĭiphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine (DTaP) or a DTaP-containing vaccine is recommended for immunization of infants and children 6 weeks through 6 years of age. doi:10.Expand Indications and Usage for Tetanus and Diphtheria Vaccineĭiphtheria and Tetanus Toxoids Adsorbed is a vaccine indicated for active immunization against diphtheria and tetanus. Tetanus: A potential public health threat in times of disaster. doi:10.15585/mmwr.mm6903a5įinkelstein P, Teisch L, Allen CJ, Ruiz G. Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis Vaccines: updated recommendations of the Advisory Committee on Immunization Practices - United States 2019. Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H. doi:10.1136/bmj.l4460Ĭenters for Disease Control and Prevention. Despite high rates of vaccination, pertussis cases are on the rise. doi:10.5812/hepatmon.22223Ĭenters for Disease Control and Prevention. Long-term T-cell-mediated immunologic memory to hepatitis B vaccine in young adults following neonatal vaccination. Saffar H, Saffar MJ, Ajami A, Khalilian AR, Shams-Esfandabad K, Mirabi AM. Updated February 29, 2019.īae C, Bourget D.
Updated December 17, 2018.Ĭenters for Disease Control and Prevention. Who should get diphtheria, tetanus, and whooping cough vaccines?.
Centers for Disease Control and Prevention.
0 kommentar(er)
